Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GENpoll: Dec 26, 2011

Obama Administration in 2011

How helpful do you think the Obama administration has been to the biopharma industry?

Very
 
  25.0%
Somewhat
 
  25.0%
Not Much
 
  46.4%
Undecided
 
  3.6%

Suggest a Poll
« More Polls » « View Results »

President Barack Obama and his administration can be expected to express fervent support for the biopharma industry and point to several accomplishments to that effect. But do the deeds match the words? On the one hand, Obama enacted patent reform sought by industry groups through the Leahy-Smith America Invents Act. Additionally, Obama’s administration pressed ahead, successfully, with NIH endorsement of human embryonic stem cell (hESC) lines; as of December 19, NIH had approved 138 hESC lines. However, that exercise may be moot depending on how a federal court rules in the new year on whether federal funding of hESC research can take place. Obama also failed to persuade Congress to reduce from 12 to seven years the data-exclusivity period for originators of biologic therapeutics, and movement on the FY 2012 budget front has been slow going. How would you rate the Obama administration’s performance.

Related content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

Insight & Intelligence™

MORE RELATED INSIGHT & INTELLIGENCE™

GEN Articles

MORE RELATED GEN ARTICLES

BLOG biotech

MORE RELATED BLOG BIOTECH

GEN Podcasts

MORE RELATED GEN PODCASTS

GEN Polls

MORE RELATED GEN POLLS

Subscription center

BACK TO TOP

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll
« More »     « View Results »     « Poll Archive »